Trial intelligence / Profile preview

Hydrocortisone for cigarette craving and tobacco withdrawal symptoms during smoking abstinence

2007-002203-40Phase 4Completed

Sponsor
St George's, University of London
Start
Aug 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of hydrocortisone in nicotine dependence (3 arms), sponsored by St George's, University of London. Primary endpoints: Desire to smoke, Tobacco withdrawal symptoms and 1 more. Started Aug 2007; status: completed.

02

Drugs

hydrocortisone
03

Conditions

nicotine dependence

Beyond the preview

Go deeper on 2007-002203-40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-002203-40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call